FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 240 filers reported holding FATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,427 | +14.6% | 673,290 | +157.4% | 0.01% | +16.7% |
| Q2 2023 | $1,245 | +225.9% | 261,611 | +590.0% | 0.01% | +140.0% |
| Q4 2022 | $382 | -100.0% | 37,915 | -64.3% | 0.01% | -80.8% |
| Q3 2022 | $2,378,000 | -29.5% | 106,125 | +86.6% | 0.03% | +23.8% |
| Q3 2021 | $3,371,000 | -65.9% | 56,876 | -50.1% | 0.02% | -76.9% |
| Q2 2021 | $9,889,000 | +570.0% | 113,943 | +601.6% | 0.09% | +203.3% |
| Q4 2020 | $1,476,000 | +232.4% | 16,241 | -43.2% | 0.03% | +42.9% |
| Q3 2019 | $444,000 | -23.8% | 28,603 | -20.2% | 0.02% | -76.9% |
| Q3 2018 | $583,000 | – | 35,845 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |